Skip to main content

Articles

ASCO 2017 - Acute Myeloid Leukemia
A Randomized Phase 2 Study Evaluating Idarubicin and Cytarabine with Clofarabine or Fludarabine in Adults with Newly Diagnosed AML
Read More
ASCO 2017 - Acute Myeloid Leukemia
Unsupervised Hierarchical Clustering of Surface Antigen Expression to Identify Patients with Normal Karyotype AML with Distinct Disease Characteristics and Poor Outcome
Read More
ASCO 2017 - Acute Myeloid Leukemia
Improved Survival with Fludarabine and Timed Sequential Busulfan Regimen in Older Patients with AML or MDS
Read More
ASCO 2017 - Acute Myeloid Leukemia
Allogeneic Transplant Leads to Markedly Improved Survival in Older Patients with Acute Myeloid Leukemia
Read More
ASCO 2017 - Acute Myeloid Leukemia
Nivolumab with Azacytidine in Patients with Relapsed AML
Read More
ASCO 2017 - Acute Myeloid Leukemia, Conference Correspondent
Suboptimal Adherence to Guideline-Recommended Molecular Testing in Patients with Newly Diagnosed AML: Data from the Connect MDS/AML Disease Registry
Read More
ASCO 2017 - Acute Myeloid Leukemia
Effect of Cytarabine/Anthracycline/Crenolanib Induction on MRD in Newly Diagnosed FLT3 Mutant AML
Read More
Prostate Cancer
A Multidisciplinary Approach to the Treatment of Prostate Cancer: Providing Therapies That Improve Overall Survival and Quality of Life
Read More
FDA Approvals
Zejula a New Maintenance Treatment Option for Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Read More
Case Study, Practice Management
Academic Detailing Has a Positive Effect on Prescribing and Decreasing Prescription Drug Costs: A Health Plan’s Perspective
Uche Anadu Ndefo, PharmD, BCPS; Rolicia Norman, PharmD; Andrea Henry, PharmD, MBA
Stakeholder Perspective
The Benefits of and Needs for Academic Detailing
Jack E. Fincham, PhD, RPh
Read More
Page 90 of 244
Results 891 - 900 of 2434